These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 39169404)

  • 1. Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study.
    Petracci E; Pasini L; Urbini M; Felip E; Stella F; Davoli F; Salvi M; Beau-Faller M; Tebaldi M; Azzali I; Canale M; Solli P; Lai G; Amat R; Carbonell C; Falcoz PE; Martinez-Marti A; Pencreach E; Delmonte A; Crinò L; Ulivi P
    J Exp Clin Cancer Res; 2024 Aug; 43(1):241. PubMed ID: 39169404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
    Genova C; Marconi S; Chiorino G; Guana F; Ostano P; Santamaria S; Rossi G; Vanni I; Longo L; Tagliamento M; Zullo L; Dal Bello MG; Dellepiane C; Alama A; Rijavec E; Ludovini V; Barletta G; Passiglia F; Metro G; Baglivo S; Chiari R; Rivoltini L; Biello F; Baraibar I; Gil-Bazo I; Novello S; Grossi F; Coco S
    Clin Exp Med; 2024 Aug; 24(1):182. PubMed ID: 39105937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC).
    Abdipourbozorgbaghi M; Vancura A; Radpour R; Haefliger S
    Br J Cancer; 2024 Nov; 131(8):1350-1362. PubMed ID: 39215192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer.
    Han B; Molins L; He Y; Viñolas N; Sánchez-Lorente D; Boada M; Guirao A; Díaz T; Martinez D; Ramirez J; Moisés J; Acosta-Plasencia M; Monzo M; Marrades RM; Navarro A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining plasma extracellular vesicle Let-7b-5p, miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction.
    Vadla GP; Daghat B; Patterson N; Ahmad V; Perez G; Garcia A; Manjunath Y; Kaifi JT; Li G; Chabu CY
    Sci Rep; 2022 Apr; 12(1):6693. PubMed ID: 35461372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients.
    Chettimada S; Lorenz DR; Misra V; Wolinsky SM; Gabuzda D
    BMC Immunol; 2020 Nov; 21(1):57. PubMed ID: 33176710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma.
    Di Paolo V; Paolini A; Galardi A; Gasparini P; De Cecco L; Colletti M; Lampis S; Raieli S; De Stefanis C; Miele E; Russo I; Di Ruscio V; Casanova M; Alaggio R; Masotti A; Milano GM; Locatelli F; Di Giannatale A
    J Exp Clin Cancer Res; 2024 Oct; 43(1):282. PubMed ID: 39385294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of microRNA-200 expression in peripheral blood-derived extracellular vesicles in early-stage non-small cell lung cancer.
    Liu L; Zhang F; Niu D; Guo X; Lei T; Liu H
    Clin Exp Med; 2024 Sep; 24(1):214. PubMed ID: 39249157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.
    Ulivi P; Petracci E; Marisi G; Baglivo S; Chiari R; Billi M; Canale M; Pasini L; Racanicchi S; Vagheggini A; Delmonte A; Mariotti M; Ludovini V; Bonafè M; Crinò L; Grignani F
    J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30678026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
    Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.